13063_2022_6033_MOESM1_ESM.pdf (1.43 MB)
Additional file 1 of Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in India
journal contribution
posted on 2022-02-01, 04:53 authored by Nandana Das, Shripad Banavali, Sameer Bakhshi, Amita Trehan, Venkatraman Radhakrishnan, Rachna Seth, Brijesh Arora, Gaurav Narula, Subir Sinha, Prakriti Roy, Manash Pratim Gogoi, Sayan Chatterjee, Bindhu Abraham, Parag Das, Vaskar Saha, Shekhar KrishnanAdditional file 1: Supplementary Table 1. List of centres participating in the ICiCLe-ALL-14 trial. Supplementary Table 2. The Indian Collaborative Childhood Leukaemia (ICiCLe) study group protocol for risk-stratified treatment of patients aged 1-18 years with first diagnosis of acute lymphoblastic leukaemia (ALL). Supplementary Table 3. SPIRIT item 3. Supplementary Figure 1. Schema of randomisation in the ICiCLe-ALL-14 protocol.
